Rosen, respected investor counsel, encourages acelrx pharmaceuticals, inc. investors with losses to secure counsel before important august 9 deadline in securities class action - acrx

New york, june 11, 2021 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of acelrx pharmaceuticals, inc. (nasdaq: acrx) between march 17, 2020 and february 12, 2021, inclusive (the "class period"). a class action lawsuit has already been filed.
ACRX Ratings Summary
ACRX Quant Ranking